Back to Search
Start Over
Mycobacterium tuberculosis PptT Inhibitors Based on Heterocyclic Replacements of Amidinoureas.
- Source :
-
ACS medicinal chemistry letters [ACS Med Chem Lett] 2023 Jun 26; Vol. 14 (7), pp. 970-976. Date of Electronic Publication: 2023 Jun 26 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- 4'-Phosphopantetheinyl transferase (PptT) is an essential enzyme for Mycobacterium tuberculosis ( Mtb ) survival and virulence and therefore an attractive target for a tuberculosis therapeutic. In this work, two modeling-informed approaches toward the isosteric replacement of the amidinourea moiety present in the previously reported PptT inhibitor AU 8918 are reported. Although a designed 3,5-diamino imidazole unexpectedly adopted an undesired tautomeric form and was inactive, replacement of the amidinourea moiety afforded a series of active PptT inhibitors containing 2,6-diaminopyridine scaffolds.<br />Competing Interests: The authors declare no competing financial interest.<br /> (© 2023 American Chemical Society.)
Details
- Language :
- English
- ISSN :
- 1948-5875
- Volume :
- 14
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- ACS medicinal chemistry letters
- Publication Type :
- Academic Journal
- Accession number :
- 37465309
- Full Text :
- https://doi.org/10.1021/acsmedchemlett.3c00162